The occurrence and density of some molluscs species in different areas of Basrah province, southern of Iraq and first record of The invasive golden mussel Limnoperna fortunei (Dunker, 1857).

The study was conducted to compare the distribution and composition of the Molluscs community in 4 ecosystems (4 sites) in southern of Iraq, namely: (Site 1)- in Euphrates River at Al-Madinah city, (Site 2)- in Shatt Al-Arab at Al-Sharsh area, (Site 3)- in the Garmat Ali River at Al-Mashib area and Site 4- in the Al-seba area. Samples were collected from study sites during a period of January to August 2019. (11) species from the class Gastropoda and (4) species from the class Bivalves, species were predominated in most of the study months which are species: Melenodies nodosa, Bellamya bengalensis and Melanopsis turbculata from Gastropoda and two of the species are bivalve: Corbicula fluminalis and Limnoperna fortunei (Dunker, 1857), and the last species, L. fortunei, was recorded in the current study for the first time in freshwater of Iraq. The total biodiversity values of Molluscs at the Euphrates River at Al-Madinah area (Site. 1), Al-Sharsh area (Site 2), Al-Mashib area (Site 3) and Al-seba area (Site 4) were 3.1, 2.9, 2.4, 1.8, respectively, and It was noted that the highest seasonal densities of the species in the current study were recorded in the winter season, reaching 1013, 905, 762 and 639 individuals / m2 in four sites, respectively.

[French recommendations on control measures to reduce the infectious risk in immunocompromised patients]. / Quelles mesures pour maîtriser le risque infectieux chez les patients immunodéprimés ? Recommandations formalisées d'experts.

The increase use of immunosuppressive treatments in patients with solid cancer and/or inflammatory diseases requires revisiting our practices for the prevention of infectious risk in the care setting. A review of the literature by a multidisciplinary working group at the beginning of 2014 wished to answer the following 4 questions to improve healthcare immunocompromised patients: (I) How can we define immunocompromised patients with high, intermediate and low infectious risk, (II) which air treatment should be recommended for this specific population? (III) What additional precautions should be recommended for immunocompromised patients at risk for infection? (IV) Which global environmental control should be recommended? Based on data from the literature and using the GRADE method, we propose 15 recommendations that could help to reduce the risk of infection in these exposed populations.

Practices of infectious control management during neutropenia: A survey from 149 French hospitals.

OBJECTIVE OF THE STUDY: Neutropenic patients represent a growing and fragile population in our hospitals. Numerous treatments induce neutropenia in haematology wards and elsewhere. Although strict isolation is recommended during post-haematopoietic stem cell transplantation neutropenia, this may not be the current practice in other situations. In this study, our objective was to analyse what protective measures are applied in neutropenic patients in a French survey. MATERIELS AND METHODS: A questionnaire was sent out to infection control teams of 400 public and private French hospitals to enquire about their local recommendations regarding infection prevention in neutropenic patients. RESULTS: Among the 166 (41%) responders, 134 (81%) managed neutropenic patients. All of the centres recommended protective isolation for neutropenic patients. However, only 46 (34%) had clearly defined patients warranting specific isolation measures in terms of the level of neutropenia. All of the centres recommended several barrier measures, but these were highly variable according to the type of air treatment in the wards (note that only 72% of haematology wards are equipped with air treatment). Gowns, gloves, masks, hats and shoe covers were respectively recommended in 128 (95%), 79 (59%), 132 (98%), 87 (65%), and 34 (25%) of the establishments. Surprisingly, the recommendations vary both among hospitals and within the same hospital among different clinical wards. CONCLUSION: In conclusion, protective measures for neutropenic patients are applied variably and urgently require a consensus to homogenize practices.

[Antituberculous activity of cyclic analogs of ethambutol]. / Activité antituberculeuse d'analogues cycliques de l'éthambutol.

The activity of new cyclopentanoic and cyclohexanoic analogues of ethambutol on various strains of mycobacteria was determined. Three compounds were effective mainly on tuberculous strains; only one was like ethambutol, being effective on both tuberculous and saprophytic strains.